Atrial fibrillation and cardiac surgery

Current Opinion in Anaesthesiology

Volumn 17, Issue 1, 2004, Pages 63-70

  McMurry, Sarah A ^a   Hogue Jr , Charles W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Cardiac surgery

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DOFETILIDE; FLECAINIDE; FUROSEMIDE; IBUTILIDE; LOCAL ANESTHETIC AGENT; METOPROLOL; OPIATE AGONIST; POTASSIUM CHANNEL; PROPAFENONE; PROPRANOLOL; SOTALOL; SPIRONOLACTONE; VERAPAMIL;

AGE DISTRIBUTION; ANTICOAGULATION; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIDURAL ANESTHESIA; FLUID RETENTION; HEART ARRHYTHMIA; HEART ATRIUM CONDUCTION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACEMAKER; HEART DEPOLARIZATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HEMODYNAMIC MONITORING; HUMAN; HYPOMAGNESEMIA; LUNG DISEASE; META ANALYSIS; OFF PUMP CORONARY SURGERY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREVALENCE; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; REVIEW; RISK FACTOR; SIDE EFFECT; SINUS RHYTHM; SYMPATHETIC TONE; THROMBOEMBOLISM; TORSADE DES POINTES;

EID: 1342301452     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200402000-00010     Document Type: Review

References (104)

1. Sra J, Dhala A, Blanck Z, et al. Atrial fibrillation: epidemiology, mechanisms, and management. Curr Probl Cardiol 2000; 25:405-424.
2. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56:539-549.
3. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996; 94:390-397.
4. Lahey SJ, Campos CT, Jennings B, et al. Hospital readmission after cardiac surgery: does 'fast track' cardiac surgery result in cost saving or cost shifting? Circulation 1998; 98(Suppl 2):II35-II40.
5. Hill LL, Kattapuram M, Hogue CW Jr. Management of atrial fibrillation after cardiac surgery. Part I: Pathophysiology and risks. J Cardiothorac Vasc Anesth 2002; 16:483-493.
6. Hill LL, De Wet C, Hogue CW Jr. Management of atrial fibrillation after cardiac surgery. Part II: Prevention and treatment. J Cardiothorac Vasc Anesth 2002; 16:626-637.
7. Jones TH, Hunter SM, Price A, Angelini GD. Should thyroid function be assessed before cardiopulmonary bypass operations? Ann Thorac Surg 1994; 58:434-436.
8. Klemperer JD, Klein IL Ojamaa K, et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg 1996; 61:1323-1327.
9. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96:3542-3548.
10. Mendes LA, Connelly G, McKenney PA, et al. Right coronary artery stenosis: an independent predictor of atrial fibrillation after coronary artery bypass surgery. J Am Coll Cardiol 1995; 25:198-202.
11. Fanning WJ, Thomas CS Jr, Roach A, et al. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass graft surgery. Ann Thorac Surg 1991; 52:529-533.
12. England MR, Gordon G, Salem M, et al. Magnesium administration and dysrhythmias after cardiac surgery: a placebo-controlled, double-blind, randomized trial. JAMA 1992; 68:2395-2402.
13. Zaman AG, Alamgir F, Richens T, et al. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart 1997; 77:527-531.
14. Toraman F, Karabulut H, Alhan C, et al. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001; 72:1256-1262.
15. Nurözler F, Tokgözog lu L, Pacao İ, et al. Atrial fibrillation after coronary artery bypass surgery: predictors and the role of MgSO4 replacement. J Card Surg 1996; 11:421-427.
16. Bert AA, Reinert SE, Singh AK. A β-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2001; 15:204-209.
17. Solomon AJ, Berger AK, Trivedi KK, et al. The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg 2000; 69:126-129.
18. Steinberg JS, Zelenkofske S, Wong SC, et al. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 1993; 88:2618-2622.
19. Hogue CW Jr, Filos KS, Schuessler RB, Sundt TM. Sinus nodal function and risk for atrial fibrillation after coronary artery bypass graft surgery. Anesthesiology 2000; 92:1286-1292.
20. Lowe JE, Hendry PJ, Hendrickson SC, Wells R. Intraoperative identification of cardiac patients at risk to develop postoperative atrial fibrillation. Ann Surg 1991; 213:388-391.
21. Hakala T, Berg E, Hartikainen JE, Hippelainen MJ. Intraoperative high-rate atrial pacing test as a predictor of atrial fibrillation after coronary artery bypass surgery. Ann Thorac Surg 2002; 74:2072-2075.
22. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II: Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991; 101:406-426.
23. Cox JL. A perspective on postoperative atrial fibrillation. Ann Thorac Surg 1993; 56:405-409.
24. Sato S, Yamauchi S, Schuessler RB, et al. The effect of augmented atrial hypothermia on atrial refractory period, conduction, and atrial flutter/fibrillation in the canine heart. J Thorac Cardiovasc Surg 1992; 104:297-306.
25. Mandapati R, Skanes A, Chen J, et al. Stable micro-reentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000; 101:194-199.
26. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659-666.
27. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92:1954-1968.
28. Ausma J, Wijffels M, Thoné F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997; 96:3157-3163.
29. Manning WJ, Silverman DI, Katz SE, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23:1535-1540.
30. Timmermans C, Rodriguez LM, Smeets JL, et al. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 1998; 9:122-128.
31. Herweg B, Dalal P, Nagy B, Schweitzer P. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am J Cardiol 1998; 82:869-874.
32. Kaiman JM, Munawar M, Howes LG, et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995; 60:1709-1715.
33. Coumel P. Heart rate variability and onset of tachyarrhythmia. G Ital Cardiol 1992; 22:647-654.
34. Franz MR, Cima R, Wang D, et al. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation 1992; 86:968-978.
35. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997; 96:1686-1695.
36. Skubas NJ, Barzilai B, Hogue CW Jr. Atrial fibrillation after CABG surgery is unrelated to transesophageal echocardiography detected cardiac abnormalities. Anesth Analg 2001; 93:14-19.
37. Shore-Lesserson L, Moskowrtz D, Hametz C, et al. Use of intraoperative transesophageal echocardiography to predict atrial fibrillation after coronary artery bypass grafting. Anesthesiology 2001; 95:652-658.
38. Smith PK, Buhrman WC, Levett JM, et al. Supraventricular conduction abnormalities following cardiac operations: a complication of inadequate atrial preservation. J Thorac Cardiovasc Surg 1983; 85:105-115.
39. Mullen JC, Khan N, Weisel, et al. Atrial activity during cardioplegia and postoperative arrhythmias. J Thorac Cardiovasc Surg 1987; 94:558-565.
40. Buffolo E, de Andrade CS, Branco JN, et al. Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thor Surg 1996; 61:63-66.
41. Abreu JE, Reilly J, Salzano RP, et al. Comparison of frequencies of atrial fibrillation after coronary artery bypass grafting with and without the use of cardiopulmonary bypass. Am J Card 1999; 83:775-776.
42. Conn WE, Sirois CA, Johnson RG. Atrial fibrillation after minimally invasive coronary artery bypass grafting: a retrospective, matched study. J Thor Cardiovasc Surg 1999; 117:298-301.
43. Stamou SC, Dangas G, Hill PC, et al. Atrial fibrillation after beating heart surgery. Am J Cardiol 2000; 86:64-67.
44. Tamis-Holland JE, Homel P, Durani M, et al. Atrial fibrillation after minimally invasive direct coronary artery bypass surgery. J Am Coll Cardiol 2000; 36:1884-1888.
45. Ascione R, Caputo M, Calori G, et al. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study. Circulation 2000; 102:1530-1535.
46. Rawles JM. What is meant by a 'controlled' ventricular rate in atrial fibrillation? Br Heart J 1990; 63:157-161.
47. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825-1833. A landmark study showing that overall patient outcomes are no different between a treatment strategy of anticoagulation and heart rate control compared with a treatment strategy of maintenance of sinus rhythm pharmacologically.
48. Mugge A, Kuhn H, Daniel WG. The role of transesophageal echocardiography in the detection of left atrial thrombi. Echocardiography 1993; 10:405-407.
49. Brown J, Sadler DB. Left atrial thrombi in non-rheumatic atrial fibrillation: assessment of prevalence by transesophageal echocardiography. Int J Card Imaging 1993; 9:65-72.
50. Klein AL, Murray RD, Grimm RA. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 2001; 37:691-704.
51. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 2001; 38:1231-1265.
52. VanderLugt JT, Mattioni T, Denker S, et al. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation 1999; 100:369-375.
53. Murray KT. Ibutilide. Circulation 1998; 97:493-497.
54. Singh S, Zobel RGH, Yellen L, et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter. Circulation 2000; 102:2385-2390.
55. Frost L, Mortensen PE, Tinglef J, et al. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Int J Cardiol 1997; 58:135-140.
56. Torp-Pedersen C, Møller M, Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med 1999; 341:857-859.
57. Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized controlled trials. Circulation 1991; 84 (Suppl I):I-236-I-244.
58. Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992; 69:963-965.
59. Janssen J, Loomans L, Harink J, et al. Prevention and treatment of supraventricular tachycardia shortly after coronary bypass grafting: a randomized open trial. Angiology 1986; 37:601-609.
60. Suttorp MJ, Kingma JH, Gin MT, et al. Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg 1990; 100:921-926.
61. Nystrom UI, Edvardsson N, Berggren H, et al. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg 1993; 41:34-37.
62. Suttorp MJ, Kingma JH, Peels HO, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 1991; 68:1163-1169.
63. Gomes JA, Ip J, Santoni-Rugiu F, et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 34:334-339.
64. Parikka H, Toivonen L, Heikkilä L, et al. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharm 1998; 31:67-73.
65. Evrard P, Gonzalez M, Jamart J, et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. Ann Thorac Surg 2000; 70:151-156.
66. Hohnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991; 121:89-95.
67. Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. Br Heart J 1993; 70:56-60.
68. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337:1785-1791.
69. Guarnieri T, Nolan S, Gottlieb SO, et al. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol 1999; 34:343-347.
70. Lee SH, Chang CM, Lu MJ, et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2000; 70:157-161.
71. Dörge H, Schoendube FA, Schoberer M, et al. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Surg 2000; 69:1358-1362.
72. Redle JD, Khurana S, Marzan R, et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 1999; 138:144-150.
73. Treggiari-Venzi MM, Waeber JL, Pemeger TV, et al. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 2000; 85:690-695.
74. Giri S, White CM, Dunn AB, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomized placebo-controlled trial. Lancet 2001; 357:830-836.
75. Tokmakoglu H, Kandemir O, Gunaydin S, et al. Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation. Eur J Cardio-Thorac Surg 2002; 21:401-405.
76. Yazigi A, Rahbani P, Zeid HA, et al. Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. J Cardiothorac Vasc Anesth 2002; 16:603-606.
77. White CM, Giri S, Tsikouris JP, et al. A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg 2002; 74:69-74.
78. Solomon AJ, Greenberg MD, Kilborn MJ, Katz NM. Amiodarone versus a β-blocker to prevent atrial fibrillation after cardiovascular surgery. Am Heart J 2001; 142:811-815.
79. Kharabsheh S, Abendroth CS, Kozak M. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol 2002; 89:896-898.
80. Kaushik S, Hussain A, Clarke P, Lazar HL. Acute pulmonary toxicity after low-dose amiodarone therapy. Ann Thorac Surg 2001; 72:1760-1761
81. Ali IM, Sanalla AA, Clark V. Beta-blocker effects on postoperative atrial fibrillation. Eur J Cardio-Thorac Surg 1997; 11:1154-1157.
82. Daubert JC, Mabo P. Atrial pacing for the prevention of postoperative atrial fibrillation: how and where to pace? J Am Coll Cardiol 2000; 35:1423-1427.
83. Gerstenfeld EP, Hill MR, French SN, et al. Evaluation of right atrial and biatrial temporary pacing for the prevention of atrial fibrillation after coronary artery bypass surgery. J Am Coll Cardiol 1999; 33:1981-1988.
84. Blommaert D, Gonzalez M, Mucumbitsi J, et al. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery. J Am Coll Cardiol 2000; 35:1411-1415.
85. Scott NB, Turfrey DJ, Ray DA, et al. A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg 2001; 93:528-535.
86. Jidéus L, Joachimsson PO, Stridsberg M, et al. Thoracic epidural anesthesia does not influence the occurrence of postoperative sustained atrial fibrillation. Ann Thorac Surg 2001; 72:65-71.
87. Gillinov AM, Blackstone EH, McCarthy PM. Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg 2002; 74:2210-2217. Concise overview of surgical options for treating atrial fibrillation are provided in this review.
88. Cox JL, Schuessler RB, D'Agostino HJ Jr, et al. The surgical treatment of atrial fibrillation. III: Development of a definitive surgical treatment. J Thorac Cardiovasc Surg 1991; 101:569-583.
89. Cox JL, Jaquiss RB, Schuessler RB, Boineau JP. Modification of the maze procedure for atrial flutter and atrial fibrillation. II: Surgical technique of the maze III procedure. J Thorac Cardiovasc Surg 1995; 110:485-495.
90. Cox JL, Schuessler RB, Boineau JP. The development of the maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000; 12:2-14.
91. McCarthy PM, Gillinov AM, Castle L, et al. The Cox-maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg 2000; 12:25-29.
92. Schaff HV, Dearani JA, Daly RC, et al. Cox-maze procedure for atrial fibrillation: Mayho Clinic experience. Semin Thorac Cardiovasc Surg 2000; 12:30-37.
93. Pasic M, Musci M, Siniawski HK, et al. Transient sinus node dysfunction after the Cox-maze III procedure in patients with organic heart disease and chronic fixed atrial fibrillation. J Am Coll Cardiol 1998; 32:1040-1047.
94. Kim KB, Lee CH, Kim CH, Cha YJ. Effect of the Cox maze procedure on the secretion of atrial naturetic peptide. J Thorac Cardiovasc Surg 1998; 115:139-147.
95. Albåge A, van der Linden J, Bengtsson L, et al. Elevations in antidiuretic hormone and aldosterone as possible causes of fluid retention in the maze procedure. Ann Thorac Surg 2001; 72:58-64.
96. Ad N, Suyderhoud JP, Kim YD, et al. Benefits of prophylactic continuous infusion of furosemide after the maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg 2002; 123:232-236.
97. Gaite F, Riccardi R, Calo L, et al. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation: electrophysiological findings and ablation results. Circulation 1998; 97:2136-2145.
98. Williams MR, Stewart JR, Bolling SF, et al. Surgical treatment of atrial fibrillation using radiofrequency energy. Ann Thorac Surg 2001; 71:1939-1944.
99. Sie HT, Beukema WP, Misier AR, et al. Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery. J Thorac Cardiovasc Surg 2001; 122:249-256.
100. Benussi S, Pappone C, Nascimbene S, et al. A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach. Eur J Cardiothorac Surg 2000; 17:524-529.
101. Pasic M, Bergs P, Muller P, et al. Intraoperative radiofrequency maze ablation for atrial fibrillation: the Berlin modification. Ann Thorac Surg 2001; 72:1484-1491.
102. Mohr FW, Fabricius AM, Falk V, et al. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: short-term and midterm results. J Thorac Cardiovasc Surg 2002; 123:919-927.
103. Spitzer SG, Richter P, Knaut M, Schuler S. Treatment of atrial fibrillation in open-heart surgery: the potential role of microwave energy. Thorac Cardiovasc Surg 1999; 47 (Suppl 3):374-378.
104. Doll N, Borger MA, Fabricius A, et al. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J Thorac Cardiovasc Surg 2003; 125:836-842.